Stories from Orlando, Florida

10.12.2019 – 01:45

UCB Pharma
UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

Brussels (ots/PRNewswire) - - Phase II data demonstrate that rozanolixizumab was well tolerated by patients with primary ITP across all dose groups - Clinically relevant improvements in platelet count and decrease in immunoglobin G (IgG) levels were observed in all dose groups - Safety, tolerability and efficacy ...

more
04.11.2019 – 18:00

Raytion GmbH
Raytion Announces the Availability of 45+ Microsoft Graph Connectors for Microsoft Search

Orlando, USA, and Düsseldorf, Germany (ots) - Raytion, an internationally operating IT business consultancy and specialist in search-based solutions and content integration, announces the availability of its Microsoft Graph connectors for Microsoft Search. Raytion's connectors integrate more than 45 on-premises and cloud content sources into Microsoft Search. Among ...

more
30.10.2019 – 11:00

Caligari Film- und Fernsehproduktions GmbH

New German TV Series "PAN TAU" Features Comedy Magician Matt Edwards

more
29.10.2019 – 09:11

Mindtree
Leading Microsoft gold competency partner to spotlight key solutions, differentiated innovation, and industry specializations on Azure

Warren, New Jersey and Bangalore, India (ots/PRNewswire) - Mindtree, a global technology services and digital transformation company, announced that it will showcase its next-generation Microsoft Azure solutions and services at Microsoft Ignite 2019, taking place Nov. 4-8 in Orlando, FL. Recognized as a 'Top ...

more
08.05.2019 – 16:53

Syntax Systems GmbH & Co. KG
SYNTAX showcases SAP portfolio at Sapphire Now at booth 1940

Montreal/Weinheim (ots) - - Global IT service provider makes first appearance in the SAP community following acquisition of FIT - Migration, cloud, and security solutions are highlighted The global IT provider SYNTAX exhibits at this year's Sapphire Now SAP conference and the ASUG Annual Conference, which currently takes place in Orlando, Florida. With the acquisition of the global IT service provider FIT (Freudenberg IT) ...

more
06.05.2019 – 11:00

itelligence AG
itelligence project wins SAP Innovation Award in "Process Innovator" category / Innovative Environmental Protection Project of itelligence AG Honored by SAP

Orlando/Bielefeld (ots) - itelligence has won an SAP Innovation Award in the "Process Innovator" category with a project involving the use of drones and image recognition for the purposes of environmental protection. These awards honor companies that operate successfully in the digital economy making use of SAP ...

more
06.05.2019 – 10:35

itelligence AG

itelligence Receives 2019 SAP® Pinnacle Award: SAP Global Platinum Reseller of the Year

more
01.05.2019 – 14:05

itelligence AG
NTT Group Brings Award-Winning Teams, Advanced Technology and Customer Focus to SAP SAPPHIRE NOW®

New York City (ots) - Two Prestigious Awards and 27 Sessions Underscore SAP Expertise and Success Meet NTT Group's family of integrated brands - NTT Communications, Dimension Data, NTT DATA, NTT Advanced Technology, everis, Secure-24 and itelligence - at Booth #421 NTT Group, represented by NTT Communications, ...

more
11.09.2018 – 12:20

Materna Information & Communications SE
Major project for Self-Bag-Drop at Denver International Airport has started with Materna / Breakthrough for Self-Bag-Drop in the US

Dortmund/Germany (ots) - In the area of self-bag-drop, Denver International Airport (DEN) is becoming a real pioneer in the USA. As part of the ongoing renovation of DEN, the redesigned airline ticket counters in the Great Hall will be equipped with the world's largest installation of self-service equipment. DEN and ...

more
23.06.2018 – 16:13

Novo Nordisk A/S
Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

Orlando, Florida (ots/PRNewswire) - Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE) study comparing the ...

more
23.06.2018 – 16:10

Novo Nordisk A/S
Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI >=25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

Orlando, Florida (ots/PRNewswire) - Poster Presentation #1083-P Ozempic® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the greatest reductions occurring in adults ...

more
23.06.2018 – 16:07

Novo Nordisk A/S
Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Orlando, Florida (ots/PRNewswire) - Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The trial evaluated the efficacy and safety of ...

more
02.04.2017 – 18:59

Novo Nordisk A/S
Once-weekly Semaglutide Demonstrated Consistent Blood Glucose Reductions and Weight Loss Regardless of Background Oral Antidiabetic Treatment

Orlando, Florida (ots/PRNewswire) - Abstract #620 Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin, exenatide extended release (ER) and insulin glargine U100 in adults with ...

more
28.05.2016 – 00:16

Novo Nordisk A/S
Semaglutide Demonstrated Superior Glycaemic Control vs Insulin Glargine U100 in Adults with Type 2 Diabetes

Orlando, Florida (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstract #290 Findings from a phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment ...

more

Research

Info

Topics

Country / Language

Presseportal App

Stories from Orlando, Florida

10.12.2019 – 01:45

UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

04.11.2019 – 18:00

Raytion Announces the Availability of 45+ Microsoft Graph Connectors for Microsoft Search

30.10.2019 – 11:00

New German TV Series "PAN TAU" Features Comedy Magician Matt Edwards

29.10.2019 – 09:11

Leading Microsoft gold competency partner to spotlight key solutions, differentiated innovation, and industry specializations on Azure

08.05.2019 – 16:53

SYNTAX showcases SAP portfolio at Sapphire Now at booth 1940

06.05.2019 – 11:00

itelligence project wins SAP Innovation Award in "Process Innovator" category / Innovative Environmental Protection Project of itelligence AG Honored by SAP

06.05.2019 – 10:35

itelligence Receives 2019 SAP® Pinnacle Award: SAP Global Platinum Reseller of the Year

01.05.2019 – 14:05

NTT Group Brings Award-Winning Teams, Advanced Technology and Customer Focus to SAP SAPPHIRE NOW®

11.09.2018 – 12:20

Major project for Self-Bag-Drop at Denver International Airport has started with Materna / Breakthrough for Self-Bag-Drop in the US

23.06.2018 – 16:13

Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

23.06.2018 – 16:10

Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI >=25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

23.06.2018 – 16:07

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

02.04.2017 – 18:59

Once-weekly Semaglutide Demonstrated Consistent Blood Glucose Reductions and Weight Loss Regardless of Background Oral Antidiabetic Treatment

28.05.2016 – 00:16

Semaglutide Demonstrated Superior Glycaemic Control vs Insulin Glargine U100 in Adults with Type 2 Diabetes

Stories from Orlando, Florida

From

To

10.12.2019 – 01:45

04.11.2019 – 18:00

30.10.2019 – 11:00

29.10.2019 – 09:11

08.05.2019 – 16:53

06.05.2019 – 11:00

06.05.2019 – 10:35

01.05.2019 – 14:05

11.09.2018 – 12:20

23.06.2018 – 16:13

23.06.2018 – 16:10

23.06.2018 – 16:07

02.04.2017 – 18:59

28.05.2016 – 00:16